Exagen Inc Stock Market Value
| XGN Stock | USD 1.36 0.03 2.16% |
| Symbol | Exagen |
Exagen Inc Price To Book Ratio
Is Exagen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exagen. If investors know Exagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exagen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Revenue Per Share 2.972 | Quarterly Revenue Growth 0.072 | Return On Assets (0.20) | Return On Equity (0.73) |
The market value of Exagen Inc is measured differently than its book value, which is the value of Exagen that is recorded on the company's balance sheet. Investors also form their own opinion of Exagen's value that differs from its market value or its book value, called intrinsic value, which is Exagen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exagen's market value can be influenced by many factors that don't directly affect Exagen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exagen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Exagen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exagen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Exagen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Exagen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Exagen.
| 04/03/2024 |
| 05/03/2024 |
If you would invest 0.00 in Exagen on April 3, 2024 and sell it all today you would earn a total of 0.00 from holding Exagen Inc or generate 0.0% return on investment in Exagen over 30 days. Exagen is related to or competes with Pulmatrix, Adial Pharmaceuticals, Jaguar Animal, and Acasti Pharma. Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products ... More
Exagen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Exagen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Exagen Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 32.68 | |||
| Value At Risk | (6.52) | |||
| Potential Upside | 4.55 |
Exagen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Exagen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Exagen's standard deviation. In reality, there are many statistical measures that can use Exagen historical prices to predict the future Exagen's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.02) | |||
| Treynor Ratio | 39.94 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Exagen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Exagen Inc Backtested Returns
Exagen Inc secures Sharpe Ratio (or Efficiency) of -0.12, which denotes the company had a -0.12% return per unit of standard deviation over the last 3 months. Exagen Inc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Exagen's Mean Deviation of 3.01, standard deviation of 4.57, and Coefficient Of Variation of (667.08) to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0174, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Exagen are expected to decrease at a much lower rate. During the bear market, Exagen is likely to outperform the market. Exagen Inc has an expected return of -0.55%. Please make sure to confirm Exagen Inc treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Exagen Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.59 |
Modest predictability
Exagen Inc has modest predictability. Overlapping area represents the amount of predictability between Exagen time series from 3rd of April 2024 to 18th of April 2024 and 18th of April 2024 to 3rd of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Exagen Inc price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Exagen price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.59 | |
| Spearman Rank Test | 0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Exagen Inc lagged returns against current returns
Autocorrelation, which is Exagen stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Exagen's stock expected returns. We can calculate the autocorrelation of Exagen returns to help us make a trade decision. For example, suppose you find that Exagen has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Exagen regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Exagen stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Exagen stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Exagen stock over time.
Current vs Lagged Prices |
| Timeline |
Exagen Lagged Returns
When evaluating Exagen's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Exagen stock have on its future price. Exagen autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Exagen autocorrelation shows the relationship between Exagen stock current value and its past values and can show if there is a momentum factor associated with investing in Exagen Inc.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| CRM | Salesforce | |
| GOOG | Alphabet Inc Class C |
Check out Exagen Correlation, Exagen Volatility and Exagen Alpha and Beta module to complement your research on Exagen. Note that the Exagen Inc information on this page should be used as a complementary analysis to other Exagen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Exagen Stock analysis
When running Exagen's price analysis, check to measure Exagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exagen is operating at the current time. Most of Exagen's value examination focuses on studying past and present price action to predict the probability of Exagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exagen's price. Additionally, you may evaluate how the addition of Exagen to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Exagen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.